pharmaphorum February 22, 2024
Phil Taylor

The US FDA has issued a warning against the use of smartwatches or smart ring devices that claim to be able to measure blood glucose levels.

The regulator points out that there are no approved blood glucose measuring devices available yet that do not require the skin to be pierced and a sample of blood taken, and any wearable device that claims to do so on its own is unapproved and could put users at risk.

These are very different from smartwatch applications that display data from FDA-approved blood glucose measuring devices that pierce the skin, like continuous glucose monitoring devices (CGMs), it adds.

The warning applies to any smartwatch or smart ring that claims to measure blood glucose without...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article